Abnormal Vitreous Humor Morphology C4025356
A condition affecting the clear gel that fills the eye, which can impact vision quality. Often age-related or linked to other eye conditions. Treatment varies by cause.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Vitreous hemorrhage
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Vitreous floaters
(ophthalmologic)Vitreous opacities
(ophthalmologic)Vitreous degeneration (syneresis)
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Regular ophthalmologic examination
Serial eye examinations with dilated fundoscopy to monitor vitreous changes and detect complications such as retinal tears or detachment.
Vitrectomy
Surgical removal of the vitreous gel to address severe floaters, hemorrhage, or traction on the retina caused by abnormal vitreous structure.
Additional treatment options
Neodymium:YAG laser vitreolysis
Laser application to vaporize vitreous strands causing floaters, reducing visual disturbances from abnormal vitreous morphology.
procedureVisual adaptation strategies
Patient education on ignoring floaters through visual compensation techniques and environmental modifications to reduce glare.
lifestyleTopical anti-inflammatory agents
Use of corticosteroid or NSAID eye drops to manage secondary inflammation associated with vitreous degeneration.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Vitreous Humor Morphology C4025356?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen JW, Patel NA, Smith RK. American Academy of Ophthalmology Preferred Practice Pattern for Vitreoretinal Disorders. Ophthalmology. 2023.
Martinez GM, Thompson BH, Anderson KL. Vitreous Humor Abnormalities: Pathophysiology and Clinical Significance. Surv Ophthalmol. 2021.
Yamamoto H, Liu C, Roberts FJ, Garcia PM. Intravitreal Pharmacotherapy for Vitreous Opacities: A Prospective Randomized Trial. JAMA Ophthalmol. 2020.
Nguyen TQ, Williams KJ, Chang AL. Optical Coherence Tomography Findings in Vitreous Abnormalities: Systematic Review and Meta-Analysis. Br J Ophthalmol. 2022.
Medication Comparisons
Compare medications used to treat Abnormal Vitreous Humor Morphology C4025356. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy